Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Dekang Biology Technology Co., Ltd. is a leading biotechnology enterprise based in Changzhou, China, specializing in the extraction of natural compounds and the production of pharmaceutical intermediates. The company is globally recognized as a pioneer in the e-liquid industry, providing high-purity nicotine solutions and flavorings for electronic cigarettes. Utilizing advanced supercritical CO2 extraction and molecular distillation technologies, Dekang produces ingredients for the pharmaceutical, food, and cosmetic sectors. The company operates extensive manufacturing facilities that adhere to international quality standards, including GMP. Dekang serves a diverse global clientele, maintaining a strong presence in Europe, North America, and Asia. Its business model encompasses both proprietary product lines and contract manufacturing services for global brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Dekang Biology.